Enzychem Lifesciences Corporation

KOSDAQ:A183490 Stock Report

Market Cap: ₩102.8b

Enzychem Lifesciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A183490?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme549,8950.689%
Individual Insiders4,141,1125.19%
Institutions4,762,5795.97%
Private Companies6,342,8307.94%
General Public64,040,82780.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 12 shareholders own 19.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.94%
Bridget Lifesciences Corporation
6,342,830₩8.2b0%no data
5.1%
Ki-Young Sohn
4,069,430₩5.2b0%no data
2.68%
The Vanguard Group, Inc.
2,138,417₩2.8b0.16%no data
2.47%
Norges Bank Investment Management
1,973,561₩2.5b0%no data
0.78%
Dimensional Fund Advisors LP
622,078₩801.2m21.9%no data
0.69%
Enzychem Lifesciences Corporation, Employee Stock Ownership Association
549,895₩708.3m0%no data
0.08%
Hye-Kyung Kim
63,810₩82.2m0%no data
0.033%
State Street Global Advisors, Inc.
26,022₩33.5m1.53%no data
0.0099%
Tae-Hoon Kim
7,872₩10.1m0%no data
0.0017%
Samsung Asset Management Company, Ltd.
1,333₩1.7m0%no data
0.001%
Mirae Asset Global Investments Co., Ltd.
798₩1.0m0%no data
0.00046%
Hi Asset Management Co., Ltd.
366₩473.0k0%no data